By freezing a crucial phosphoric acid complex to near absolute zero, scientists uncovered a single, unexpectedly stable structure at the heart of proton transport.

Erasca (NASDAQ:ERAS) executives outlined the company’s strategy to target RAS-driven cancers and previewed upcoming clinical ...

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

Reducing the dose of biologic drugs may not match standard treatment in preventing disease flares at 1 year in patients with rheumatoid arthritis in remission, a phase 4 study finds.

"Dosing the first patient in Phase III represents a major milestone for MDR-001 and for AI-enabled drug development," said Zhangming Niu, Founder and Chief Executive Officer of MindRank. "We believe ...

Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects ...

Scientists from Duke-NUS Medical School, working with collaborators at Imperial College London and partners in Europe and the United States, have uncovered new insights into how an additional copy of ...

Science is a subject built on doing. Students learn chemistry through titrations, biology through dissections, physics ...

The genetic network of BTB zinc finger transcription factors and Eip93F is crucial for Kenyon cell identity regulation and neuronal function acquisition in the construction of Drosophila mushroom ...

Scientists are exploring pig skin to gain a fuller understanding of how this process works. The result could mean uncovering ...

ATRIMED, a research-driven life sciences company specializing in plant-based innovation, today announced a major milestone in its effort to transform ancient medical knowledge into structured, machine ...

A research team led by Professor Ki-Young Lee at the College of Medicine, Sungkyunkwan University, has uncovered a previously unrecognized tumor-intrinsic role of the immune checkpoint molecule PD-L1, ...